Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Scopus BioPharma Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 28 | 15 | −13 |
| Shares | 579.1K | 149.9K | −429.1K (−74.1%) |
| Value | $4.89M | $1.07M | −$3.82M (−78.1%) |
New holders (3)
Institutions that held Scopus BioPharma Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 23,450 | $167.0K | 0.00% |
| ExodusPoint Capital Management, LP | 16,069 | $115.0K | 0.00% |
| Captrust Financial Advisors | 95 | $1.00K | 0.00% |
Sold out (16)
Institutions that held Scopus BioPharma Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Millennium Management LLC | 92,104 | $778.0K |
| Geode Capital Management, LLC | 52,159 | $440.0K |
| Northern Trust Corp | 47,633 | $403.0K |
| State Street Corp | 40,754 | $344.0K |
| Vanguard Group Inc | 24,187 | $205.0K |
| Two Sigma Advisers, LP | 19,500 | $165.0K |
| Susquehanna International Group, LLP | 14,799 | $125.0K |
| Charles Schwab Investment Management Inc | 11,810 | $100.0K |
| California State Teachers Retirement System | 8,365 | $71.0K |
| Deutsche Bank AG | 3,495 | $30.0K |
| American International Group, Inc. | 3,232 | $27.0K |
| Wells Fargo & Company | 2,188 | $18.0K |
| STRS Ohio | 1,300 | $10.0K |
| Legal & General Group Plc | 541 | $5.00K |
| Ameritas Investment Partners, Inc. | 450 | $4.00K |
| Bank of Montreal | 354 | $3.00K |